Clinical Trial Update: Randomized Phase III Trial of Surgery Alone or Surgery Plus Preoperative Gemcitabine-Cisplatin in Early Stages NSCLC [Phase 3]

View source ↗

Summary

A randomized Phase III trial comparing surgery alone to surgery plus preoperative gemcitabine-cisplatin in early-stage non-small cell lung cancer has been compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• gemcitabine/cisplatin

Snippet

Sponsor: Eli Lilly and Company | Conditions: Non-Small Cell Lung Cancer | Phase 3 | Status: COMPLETED